What is it about?

Initiation of oral ondansetron vs. comparator antimetics with lesser QT interval-prolonging potential is associated with a higher 10-day risk of sudden cardiac death among people receiving in-center hemodialysis.

Featured Image

Read the Original

This page is a summary of: Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis, Journal of the American Society of Nephrology, February 2024, Wolters Kluwer Health,
DOI: 10.1681/asn.0000000000000336.
You can read the full text:

Read

Contributors

The following have contributed to this page